Japan is the fastest aging country in the world. With about 125 million people now, their population is expected to decline to 90 million in 25 years. In an effort to increase their population, starting this month, Japan will begin to reimburse more treatments for infertility. Therapies with reproductive applications, embryo transfer, artificial insemination, etc. will be reimbursed. Many new drugs for assisted reproductive technologies have been approved and more are in process. Other treatments like sperm injection, preimplantation genetic testing, egg stimulation, etc. will soon be reimbursed too. This will create new opportunities that focus on this sector.
Written by: Ames Gross – President and Founder, Pacific Bridge Medical (PBM)
Mr. Gross founded PBM in 1988 and has helped hundreds of medical companies with regulatory and business development issues in Asia. He is recognized nationally and internationally as a leader in the Asian medical markets. Mr. Gross has a BA degree, Phi Beta Kappa, from the University of Pennsylvania and an MBA from Columbia University.